Search

everythinglearnresearchcommunity

for

Search:↓

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Locally made finasteride tablets work the same as imported ones.

The two finasteride tablet brands are bioequivalent.

Injectable biomimetic gels can help heal tissues and deliver drugs but need improvements in strength and delivery.

New drug shows promise for better hair growth in baldness treatment.

Finasteride's two formulations absorb similarly, showing bioequivalence.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

Bioinspired polymers are promising for advanced medical treatments and tissue repair.

Cosmeceuticals effectively treat skin issues but need better regulation and safety measures.

New technologies replicate human skin for testing without animals.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Bioengineered skin models help reduce animal testing and advance research in cosmetics and skin disease.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.